Skip to content
PubMed This is a summary of 7 peer-reviewed journal articles Updated
Maternal-Fetal Medicine · Trisomy 18

What Does Mosaic Trisomy 18 on CVS With Normal Amnio Mean?

At a Glance

A normal amniocentesis after mosaic trisomy 18 on CVS usually means the extra chromosome 18 cells are confined to the placenta, not the baby. It is reassuring, but growth monitoring is still important because placental mosaicism can affect growth and a small residual risk remains.

Getting two different results from prenatal genetic tests is a recognized, albeit stressful, situation. When a chorionic villus sampling (CVS) shows some cells with trisomy 18 (mosaic trisomy 18) but a follow-up amniocentesis is normal, it most often means the abnormal cells are confined to the placenta. This scenario provides strong reassurance that the baby’s chromosomes are likely normal, but the pregnancy will still require close monitoring to ensure the placenta is functioning well and the baby is growing appropriately.

The Bottom Line

  • A Reassuring Result: A normal amniocentesis after a mosaic CVS strongly suggests the trisomy 18 cells are confined placental mosaicism (CPM)—meaning they are detected only in the sampled placental tissue, not in the baby [1].
  • Ongoing Monitoring is Needed: Because the placenta supports the baby, having abnormal cells there can affect its function, increasing the risk of fetal growth restriction [2]. Your doctor will likely recommend extra ultrasounds to monitor the baby’s size.
  • Residual Risk: While highly accurate, an amniocentesis cannot sample every tissue in the baby’s body. True fetal mosaicism remains a small, residual possibility [3].

Why Do the Results Differ?

To understand how these tests can give different answers, it helps to know what they are actually testing:

  • CVS takes a sample from the placenta early in pregnancy. The placenta and the baby develop from the same initial cells, but as they divide, a genetic error like trisomy 18 can sometimes occur only in the cells destined to become the placenta.
  • Amniocentesis takes a sample of the amniotic fluid, which contains cells shed directly by the fetus (such as skin and urinary tract cells).

When the CVS shows an abnormality but the amniocentesis does not, the most common explanation is confined placental mosaicism (CPM) [1]. If the abnormal cells are truly confined to the placenta, the fetus is not expected to have trisomy 18.

What Confined Placental Mosaicism Means for Your Pregnancy

Even if your baby is unaffected, having a mosaic placenta means your pregnancy is considered higher risk for certain complications.

  • Fetal Growth Restriction (FGR): The primary concern with CPM is how well the placenta functions. Research shows that pregnancies with confined placental mosaicism have increased odds of fetal growth restriction (where the baby does not grow as well as expected) and of the infant being born small for their gestational age (SGA) [2].
  • Monitoring Schedule: To watch for this, your maternal-fetal medicine team will likely recommend an individualized schedule of serial ultrasounds in the second and third trimesters. These scans monitor the baby’s growth, amniotic fluid volume, and sometimes blood flow through the umbilical cord (using Doppler ultrasound). It is important to know that while the risk of growth restriction is higher, many pregnancies with CPM go on to have completely normal growth and healthy outcomes.

Could the Baby Still Have Trisomy 18?

An amniocentesis is usually the most informative prenatal chromosome test, but it cannot guarantee with absolute certainty that every single cell in the baby is normal. This is due to two factors:

  1. Tissue Differences (True Fetal Mosaicism): True fetal mosaicism happens when a baby has a mixture of normal and trisomy 18 cells distributed unevenly throughout the body. It is biologically possible for a baby to have mosaic trisomy 18 in specific tissues (like blood or skin) even if the amniotic fluid tested completely normal [3].
  2. Testing Limitations: The exact tests run on the amniotic fluid matter. Standard chromosome analysis (karyotyping) requires growing the cells in a lab for several days, which can occasionally miss a low proportion of abnormal cells [4]. Other methods, like FISH (Fluorescence In Situ Hybridization) or chromosomal microarray, analyze cells differently and look for smaller changes or test uncultured cells. No single test is categorically “better” or perfect; they have different detection limits, and a genetic counselor can explain which methods were used and how reassuring they are [4].

Interpretation also depends heavily on your specific CVS lab report—such as the percentage of abnormal cells and whether they were found in the direct preparation or the cultured cells [5].

Next Steps and Further Reassurance

Because an amniocentesis cannot sample every tissue, your medical team may recommend additional steps to gather more information about your baby’s health:

  • Detailed Anatomy Ultrasound: A detailed structural scan provides substantial reassurance against the major patterns typically associated with full trisomy 18. In studies of full trisomy 18, up to 95% of fetuses had at least one visible abnormality on a detailed ultrasound [6]. While a normal scan cannot rule out mosaicism or guarantee perfect health, it is a very positive sign.
  • Fetal Echocardiogram: Because congenital heart defects are common in trisomy 18 (reported in over 70% of fetuses in clinical cohorts), your doctor may discuss a targeted fetal echocardiogram [7]. This specialized ultrasound looks closely at the structure of the baby’s heart. A normal echo is reassuring, though it cannot rule out every possible heart defect.
  • Postnatal Testing: After birth, a pediatrician or geneticist may discuss evaluating the baby and testing a sample of the baby’s cord blood, peripheral blood, or cheek swab (buccal cells) [3]. While postnatal testing is highly individualized and no single tissue sample can completely rule out mosaicism everywhere in the body, it can help confirm the prenatal findings and provide more clarity.

Navigating discordant test results can feel like an emotional rollercoaster. Reviewing your exact laboratory reports with a genetic counselor or maternal-fetal medicine specialist is the best way to understand your individualized residual risk and establish a personalized care plan.

Common questions in this guide

How reassuring is a normal amniocentesis after mosaic trisomy 18 is found on CVS?
A normal amniocentesis is generally strongly reassuring and most often suggests confined placental mosaicism, meaning the abnormal cells are limited to the placenta. The fetus is likely not to have trisomy 18, but amniocentesis cannot test every tissue, so a small residual possibility of fetal mosaicism remains.
What is confined placental mosaicism, and why does it matter?
Confined placental mosaicism means that some placental cells have an extra copy of chromosome 18 while the fetus may not. Even when the fetus is unaffected, the placenta may not function normally, which can increase the risk of fetal growth restriction or a baby being small for gestational age.
Could a baby still have mosaic trisomy 18 if the amniocentesis is normal?
Rarely, true fetal mosaicism can be present in tissues that are not represented in the amniotic fluid or at a level below the test's detection limit. The remaining risk depends on the CVS findings and the specific amniocentesis methods used, such as karyotyping, FISH, or chromosomal microarray.
What monitoring is recommended after these conflicting prenatal test results?
A maternal-fetal medicine team may recommend a detailed anatomy ultrasound and serial scans to track fetal growth, amniotic fluid, and sometimes blood flow through the umbilical cord. A targeted fetal echocardiogram may also be discussed to examine the baby's heart more closely.
Can testing after birth clarify whether a baby has mosaic trisomy 18?
A pediatrician or geneticist may discuss testing cord blood, peripheral blood, or cheek cells after birth. These tests can provide additional information and help confirm the prenatal findings, although no single sample can completely rule out mosaicism in every tissue.

Get notified when new evidence is published on Trisomy 18 syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (7)
  1. 1

    The type of feto-placental aneuploidy detected by cfDNA testing may influence the choice of confirmatory diagnostic procedure.

    Grati FR, Bajaj K, Malvestiti F, et al.

    Prenatal diagnosis 2015; (35(10)):994-8 doi:10.1002/pd.4659.

    PMID: 26211640
  2. 2

    Pregnancy outcome of confined placental mosaicism: meta-analysis of cohort studies.

    Spinillo SL, Farina A, Sotiriadis A, et al.

    American journal of obstetrics and gynecology 2022; (227(5)):714-727.e1 doi:10.1016/j.ajog.2022.07.034.

    PMID: 35934121
  3. 3

    Prenatal diagnosis of mosaic trisomy 18 and maternal uniparental disomy 18 by amniocentesis in a pregnancy associated with cytogenetic discrepancy in various tissues and a favorable fetal outcome.

    Chen CP, Wu FT, Pan YT, et al.

    Taiwanese journal of obstetrics & gynecology 2023; (62(4)):606-610 doi:10.1016/j.tjog.2023.05.012.

    PMID: 37407205
  4. 4

    Cytogenetic discrepancy between uncultured amniocytes and cultured amniocytes in mosaic trisomy 18 at amniocentesis in a pregnancy with a favorable fetal outcome and maternal uniparental disomy 18.

    Chen CP, Su JW, Chern SR, et al.

    Taiwanese journal of obstetrics & gynecology 2022; (61(4)):684-689 doi:10.1016/j.tjog.2022.05.005.

    PMID: 35779922
  5. 5

    Chorionic Villus Sampling for Rapid Confirmation of High-Risk NIPT Results for Trisomy 21, 18, and 13.

    Srebniak MI, Weerts M, Joosten M, et al.

    Prenatal diagnosis 2025; (45(8)):988-993 doi:10.1002/pd.6837.

    PMID: 40528522
  6. 6

    Sensitivity of prenatal ultrasound for detection of trisomy 18.

    Becker DA, Tang Y, Jacobs AP, et al.

    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2019; (32(22)):3716-3722 doi:10.1080/14767058.2018.1471460.

    PMID: 29712489
  7. 7

    Prenatal echocardiography in Trisomy 18 - the key to diagnosis and further management in the second half of pregnancy.

    Nowakowska A, Sylwestrzak O, Strzelecka I, et al.

    Ginekologia polska 2023; (94(5)):366-373 doi:10.5603/GP.a2023.0035.

    PMID: 37070966

This information explains discordant CVS and amniocentesis results for educational purposes only and does not replace medical advice. Your maternal-fetal medicine specialist and genetic counselor should interpret your reports and recommend monitoring for your pregnancy.